Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine

Insights

Alternative splicing of the mu opioid receptor gene (OPRM1) creates variants impacting morphine effects. Truncating C-terminal tails reveals distinct roles in tolerance, reward, and desensitization.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Genetics

Background:

  • Alternative splicing of the mu opioid receptor gene (OPRM1) generates numerous C-terminal variants.
  • The behavioral significance of these OPRM1 splice variants is largely unexplored.

Purpose of the Study:

  • To investigate the functional roles of OPRM1 C-terminal splice variants in morphine-induced behaviors.
  • To generate and characterize mouse models with specific truncations of OPRM1 C-terminal tails.

Main Methods:

  • Generated three mutant mouse models (mE3M, mE4M, mE7M) in C57BL/6J and 129/SvEv strains with truncated OPRM1 C termini.
  • Assessed morphine-induced behaviors including tolerance, reward, and physical dependence.
  • Conducted cell-based assays to examine receptor signaling bias and desensitization.

Main Results:

  • Truncations differentially affected morphine tolerance, reward, and dependence.
  • Exon 7 truncation diminished tolerance and reward but not dependence.
  • Exon 4 truncation enhanced tolerance and reduced dependence.
  • mE7M mice showed loss of morphine-induced desensitization in specific brain regions.
  • Cell studies indicated exon 7 variants bias mu opioid signaling towards β-arrestin 2.

Conclusions:

  • OPRM1 C-terminal splice variants play critical, distinct roles in mediating complex morphine actions.
  • Alternative splicing of OPRM1 is pharmacologically significant for opioid drug effects.
  • Exon 7-associated variants are implicated in morphine tolerance via β-arrestin 2 interactions.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.0K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
908
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
848
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.9K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.3K